Binding of a Novel 11β-Hydroxysteroid to the Apelin Receptor (APLNR) and Its Possible Role in Regulating Skeletal Muscle Health in Mice
- 1Laboratorio de Investigación Integral Cardiometabólica, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico
- 2Sección de Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico
Abstract
Several molecules have been investigated for their potential to improve muscle health in models of muscle damage simulating sarcopenia, injury, or aging. Some small molecules induced beneficial effects on skeletal muscle by stimulating the apelin receptor (APLNR). This receptor has emerged as a promising pharmacological target for modulating muscle homeostasis. Using an in silico approach, we recently identified 11β-hydroxypregnenolone (11β-OHP5) as a potential skeletal muscle (SKM) modulator. We hypothesized that 11β-OHP5 interacts with and activates APLNR. This study employed several research approaches: (1) in silico molecular docking and molecular dynamics to explore the feasibility of 11β-OHP5 interacting with APLNR; (2) in vitro activation analysis to APLNR; (3) in vitro analysis C2C12 myoblast differentiation; (4) analysis of the molecule’s presence in mouse skeletal muscle and its differential presence between young and older mice. The results show that 11β-OHP5, acting through APLNR, positively affects myoblast differentiation and may participate in the exercise-induced benefits in aging mice. We show that 11β-OHP5 interacts with APLNR, induces myogenic responses, is found in SKM; its concentration decreases with age, and exercise restores it. More work is necessary to understand the physiology of this possible endogenous molecule.
Related
- miR-191 affects skeletal muscle differentiation by regulating Wwp1 in mouse myoblasts
- Exercise, skeletal muscle and inflammation: ARE-binding proteins as key regulators in inflammatory and adaptive networks
- Esketamine exerts a protective effect against skeletal muscle injury induced by hindlimb ischemia-reperfusion in mice by regulating autophagy
- N-Glycosylation in the Receptor Binding Domain serves as aggregation gatekeeper of the SARS CoV2 Spike glycoprotein folding
- Resistance to thyroid hormone alpha associated with a novel THRA ligand-binding domain variant: familial clinical, biochemical, skeletal, and exploratory cerebral FDG-PET/CT metabolic findings
BibTeX
@article{gonzalezperez2026binding,
title = {{Binding of a Novel 11β-Hydroxysteroid to the Apelin Receptor (APLNR) and Its Possible Role in Regulating Skeletal Muscle Health in Mice}},
author = {Marcos González-Pérez and Citlali Gómez-Márquez and Miguel Ortiz-Flores and Marycarmen Godínez-Victoria and Nayelli Nájera and Guillermo Ceballos},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209379},
url = {https://www.mdpi.com/1422-0067/27/20/9379},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Binding of a Novel 11β-Hydroxysteroid to the Apelin Receptor (APLNR) and Its Possible Role in Regulating Skeletal Muscle Health in Mice
AU - Marcos González-Pérez
AU - Citlali Gómez-Márquez
AU - Miguel Ortiz-Flores
AU - Marycarmen Godínez-Victoria
AU - Nayelli Nájera
AU - Guillermo Ceballos
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209379
UR - https://www.mdpi.com/1422-0067/27/20/9379
AB - Several molecules have been investigated for their potential to improve muscle health in models of muscle damage simulating sarcopenia, injury, or aging. Some small molecules induced beneficial effects on skeletal muscle by stimulating the apelin receptor (APLNR). This receptor has emerged as a promising pharmacological target for modulating muscle homeostasis. Using an in silico approach, we recently identified 11β-hydroxypregnenolone (11β-OHP5) as a potential skeletal muscle (SKM) modulator. We hypothesized that 11β-OHP5 interacts with and activates APLNR. This study employed several research approaches: (1) in silico molecular docking and molecular dynamics to explore the feasibility of 11β-OHP5 interacting with APLNR; (2) in vitro activation analysis to APLNR; (3) in vitro analysis C2C12 myoblast differentiation; (4) analysis of the molecule’s presence in mouse skeletal muscle and its differential presence between young and older mice. The results show that 11β-OHP5, acting through APLNR, positively affects myoblast differentiation and may participate in the exercise-induced benefits in aging mice. We show that 11β-OHP5 interacts with APLNR, induces myogenic responses, is found in SKM; its concentration decreases with age, and exercise restores it. More work is necessary to understand the physiology of this possible endogenous molecule.
SN - 1422-0067
ER -